Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity
- 31 December 2008
- journal article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 40 (5), 1030-1042
- https://doi.org/10.1016/j.biocel.2007.11.003
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and XenograftsCancer Research, 2007
- Protection of Human Vascular Smooth Muscle Cells From H 2 O 2 -Induced Apoptosis Through Functional Codependence Between HO-1 and AKTArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders.Current Alzheimer Research, 2006
- The oxidative neurotoxicity of clioquinolNeuropharmacology, 2005
- Copper-Dependent Inhibition of Human CytochromecOxidase by a Dimeric Conformer of Amyloid-β1-42Journal of Neuroscience, 2005
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- Synergistic lethal effect between hydrogen peroxide and neocuproine (2,9-dimethyl 1,10-phenanthroline) in Escherichia coliMutation Research/DNA Repair, 1999
- Hydrogen peroxide mediates amyloid β protein toxicityCell, 1994
- Intramuscular desferrioxamine in patients with Alzheimer's diseaseThe Lancet, 1991